SCbio has reiterated its support of the South Carolina Department of Commerce in recognizing the life sciences industry as a key business sector for economic growth in the Palmetto State.
Through data-driven research, S.C. Commerce has identified the life sciences as one of the long-term areas of focus to enhance economic prosperity.
“The work of SC Commerce makes it clear that when investments are made in South Carolina’s life sciences industry, they will pay off for our residents and economy,” SCbio President and CEO James Chappell said in January.
He added, “The life sciences industry makes South Carolina competitive - it is creating high-wage jobs, developing breakthrough treatments and technologies, and attracting top talent with its acclaimed academic and research institutions.”
“South Carolina is advancing the future as the new home of American innovation,” said Secretary Harry M. Lightsey III. “Driven to create long-term opportunities for the people who call our state home, S.C. Commerce is actively diversifying its industry portfolio by targeting sectors such as life sciences. Our message to life sciences companies is that South Carolina is the place to be from Launch to Legacy!”
The comments were echoed Feb. 7, 2024, at the Hyatt Regency Greenville as several hundred industry leaders, biotech and pharma executives, medical device and medtech innovators, digital health experts, educators and life sciences supporters gathered for the 2024 SCbio Annual Conference.
Robert Coughlin, managing director of JLL and former CEO of MassBio, recounted his son’s struggle with cystic fibrosis, and how a Vertex Pharmaceuticals drug saved his son’s life.
Sarah Kleinpeter. vice president/Alzheimer's Disease for Novo Nordisk, detailed how dramatic progress is being made and why there is now real hope to prevent and even reverse Alzheimer’s Disease and cognitive decline.
Gov. Henry McMaster, who attended the conference, has made life sciences a top state priority and said officials will work to grow and expand the industry in the Palmetto State.
SCbio is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.
SCbio represents more than 1,000 organizations employing more than 87,000 professionals across the state and supports and advances organizations in multiple arenas including pharmaceuticals, medical devices and equipment, digital health, research and medical labs, bioscience distribution, bio-ag and more.
For additional information about SCbio and the life sciences industry, go to www.SCbio.org.